WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005095411) FUROCHROMENE DERIVATIVE WITH ANTI-INFLAMMATORY ACTIVITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/095411    International Application No.:    PCT/HR2005/000022
Publication Date: 13.10.2005 International Filing Date: 30.03.2005
IPC:
A61K 31/37 (2006.01), C07D 493/04 (2006.01)
Applicants: PLIVA-ISTRAZIVACKI INSTITUT D.O.O. [HR/HR]; Prilaz baruna Filopovica 29, 10000 Zagreb (HR) (For All Designated States Except US).
MERCEP, Mladen [HR/HR]; (HR) (For US Only).
MESIC, Milan [HR/HR]; (HR) (For US Only).
BOSKA, Hrvacic [HR/HR]; (HR) (For US Only).
IVAYLO, Jivkov, Elenkov [HR/HR]; (HR) (For US Only).
IVICA, Malnar [HR/HR]; (HR) (For US Only)
Inventors: MERCEP, Mladen; (HR).
MESIC, Milan; (HR).
BOSKA, Hrvacic; (HR).
IVAYLO, Jivkov, Elenkov; (HR).
IVICA, Malnar; (HR)
Common
Representative:
PLIVA-ISTRAZIVACKI INSTITUT D.O.O.; Pravni Patentni Poslovi, Prilaz baruna Filopovica 29, 10000 Zagreb (HR)
Priority Data:
P20040318A 02.04.2004 HR
Title (EN) FUROCHROMENE DERIVATIVE WITH ANTI-INFLAMMATORY ACTIVITY
(FR) DERIVE DE FUROCHROMENE A ACTIVITE ANTI-INFLAMMATOIRE
Abstract: front page image
(EN)This invention relates to the novel compound of formula (I): and pharmaceutically acceptable salts and solvates thereof; to the processes and reactive intermediates for the preparation of this compound, pharmaceutical compositions which contain this compound, and the use of this compound in prophylaxis and therapeutic treatment of asthma as well as other diseases, disorders or conditions of human immune system.
(FR)La présente invention a trait à un nouveau composé de formule (I), et ses sels et solvates pharmaceutiquement acceptables ; à des procédés et des intermédiaires réactifs pour la préparation dudit composé, à des compositions pharmaceutiques contenant ledit composé, et à l'utilisation dudit composé dans la prophylaxie et le traitement thérapeutique de l'asthme ainsi que d'autres maladies, troubles ou conditions du système immunitaire humain.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)